DAP Health has received the new twice-yearly injection for HIV prevention. Here's what you need to know if you're interested ...

Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.

Chicago-area groups that support LGBTQ+ individuals are navigating an uncertain landscape while bracing for federal funding ...

Why a twice‑yearly injection might prove to be a good shot Lenacapavir is a first-in-class HIV drug that works by targeting ...

HIV prevention is entering a new phase with the rise of innovative medications like the twice-yearly injectable lenacapavir.

DAP Health is presenting “Next Gen Care: A Community Conversation on HIV Prevention,” an event that will highlight ...

Congress removed from a list of programmes from which the Trump administration wants to cut funds, doesn’t cancel the cuts to ...

This month, the White House released a statement that confirmed Trump “underwent a comprehensive examination” that revealed he had chronic venous insufficiency. Here's what that means, according to ...